ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 114 | 183 | 81 | 57 | 143 |
| Gross Profit | 114 | 183 | 81 | 57 | 143 |
| Operating Expenses | 8,505 | 13,211 | 13,146 | 16,500 | 13,312 |
| Operating Income | -8,391 | -13,028 | -13,065 | -16,443 | -13,168 |
| Interest Expense | 166 | 172 | 172 | 172 | 172 |
| Other Income | 1,908 | 467 | -1,738 | -636 | 69 |
| Pre-tax Income | -6,649 | -12,734 | -14,975 | -17,251 | -13,272 |
| Net Income Continuous | -6,649 | -12,734 | -14,975 | -17,251 | -13,272 |
| Net Income | $-6,649 | $-12,734 | $-14,975 | $-17,251 | $-13,272 |
| EPS Basic Total Ops | -1.56 | -4.38 | -5.76 | -7.20 | -6.54 |
| EPS Basic Continuous Ops | -1.43 | -4.39 | -5.74 | -7.32 | -6.62 |
| EPS Diluted Total Ops | -1.56 | -4.38 | -5.76 | -7.20 | -6.54 |
| EPS Diluted Continuous Ops | -1.43 | -4.39 | -5.74 | -7.32 | -6.62 |
| EBITDA(a) | $-8,361 | $-12,993 | $-13,024 | $-16,401 | $-13,129 |